University of Galway have made a breakthrough in understanding the body’s response to bowel cancer, opening up new treatment possibilities for people.

BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...

Imaging data from the phase 2 MINDFuL trial in Alzheimer’s Disease should be released in Q4 2025. Final data on the INKmune CARE-PC trial is expected in Q4 2025. Financial Results for the Third ...

Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Nanoparticles carrying IL-12 are non-toxic, elicit strong systemic antitumor immunity, and sensitize ovarian tumors to ICI therapy, a new study shows.

Niraparib significantly improved PFS and time without symptoms for women with advanced ovarian cancer who responded to ...

Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed the rationale behind paclitaxel with bevacizumab ...